Business Context and Reporting Period
This Form 6-K filing by Medirom Healthcare Technologies Inc. is dated August 7, 2026. The report addresses a regulatory compliance issue regarding the company's listing status on The Nasdaq Stock Market LLC.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance data.
Material Changes
The primary material event is the company's failure to comply with Nasdaq Listing Rule 5250(c)(1) due to a delay in filing its Form 20-F for the fiscal year ended December 31, 2025. Following a notice received on May 26, 2026, the company submitted a compliance plan and was granted an extension until November 11, 2026, to regain compliance.
Outlook, Risks, and Contingencies
- Delisting Risk: If the company fails to regain compliance by November 11, 2026, Nasdaq will notify the company that its American Depositary Shares will be delisted.
- Appeal Process: In the event of a delisting determination, the company may appeal to a Nasdaq Hearings Panel.
- Forward-Looking Statements: The company cautions that there is no assurance it will regain compliance within the extended period. Actual results may differ materially from expectations due to significant risks and uncertainties.
Key Facts for Investor Verification
- Verify the current status of the Form 20-F for the fiscal year ended December 31, 2025.
- Monitor the November 11, 2026 deadline for regaining Nasdaq compliance.
- Assess the potential impact of delisting on the liquidity and trading of American Depositary Shares.
- Review the "Risk Factors" section of the Annual Report on Form 20-F filed on April 29, 2025, for detailed risk disclosures.